All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
ARWR real return snapshot: after CPI-U inflation, ARWR returned +56.18% over the past year and −15.56% YTD, with dividends reinvested. Since Dec. 16, 1993, ARWR is down −99.14% in real purchasing-power return, or −13.48%/yr.
Data ending Wed Oct. 14, 2026
| Thu 1993-12-16💬 to Wed 2026-10-14 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| ARWR × |
−99.14%
−13.48%/yr |
−4.85%/yr
R2=0.099 |
||||
| Arrowhead Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Thu 1993-12-16💬 to Wed 2026-10-14 |
Start
Value |
End
Value |
|---|---|---|
| ARWR × |
$10,000.00
1993-12-16 |
$86.23
2026-10-14 |
| YTD | YoY | |
|---|---|---|
| ARWR × | −15.56% | +56.18% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| ARWR × |
−99.14%
on 2026-10-14 |
−99.97%
on 2016-12-16 |
| Period ending Wed 2026-10-14 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| ARWR × | +56.18% |
+181.89% +67.90%/yr |
+100.14% +26.02%/yr |
−28.73% −6.55%/yr |
+529.36% +20.20%/yr |
| Year | ARWR |
|---|---|
| 2026 (YTD) | −15.56% |
| 2025 | +243.94% |
| 2024 | −40.28% |
| 2023 | −27.00% |
| 2022 | −42.54% |
| 2021 | −19.27% |
| 2020 | +19.34% |
| 2019 | +399.30% |
| 2018 | +231.19% |
| 2017 | +132.51% |
| 2016 | −75.31% |
| 2015 | −17.27% |
| 2014 | −32.49% |
| 2013 | +399.50% |
| 2012 | −49.80% |
| 2011 | −54.53% |
| 2010 | +66.38% |
| 2009 | −43.92% |
| 2008 | −75.68% |
| 2007 | −17.09% |
| 2006 | +0.53% |
| 2005 | −4.88% |
| 2004 | +221.83% |
| 2003 | +227.21% |
| 2002 | −60.92% |
| 2001 | −76.37% |
| 2000 | +20.90% |
| 1999 | −39.13% |
| 1998 | +57.46% |
| 1997 | −68.54% |
| 1996 | −39.51% |
| 1995 | −80.68% |
| 1994 | −55.30% |
| 1993 | −38.89% |
